Gyre Therapeutics (GYRE) EBT Margin Growth (5y) (2015 - 2026)
Gyre Therapeutics (GYRE) EBT Margin Growth (5y) (2015 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
| 10 |
Gyre Therapeutics |
554.75 Mn |
540.62 Mn |
8.38 Mn |
| Date | Value |
|---|
| Mar 31, 2026 |
148,734.00 |
| Dec 31, 2025 |
90,944.00 |
| Sep 30, 2025 |
182,037.00 |
| Jun 30, 2025 |
104,865.00 |
| Mar 31, 2025 |
4,994.00 |
| Mar 31, 2023 |
8.41 Mn |
| Dec 31, 2022 |
185,301.00 |
| Mar 31, 2022 |
-30,379.00 |
| Dec 31, 2021 |
444,935.00 |
| Sep 30, 2021 |
327,998.00 |
| Jun 30, 2021 |
267,573.00 |
| Mar 31, 2021 |
176,706.00 |
| Dec 31, 2020 |
500,734.00 |
| Sep 30, 2020 |
151,835.00 |
| Jun 30, 2020 |
-53,552.00 |
| Mar 31, 2020 |
97,271.00 |
| Mar 31, 2018 |
-8.38 Mn |
| Dec 31, 2017 |
84,080.00 |
| Sep 30, 2017 |
-79,579.00 |
| Jun 30, 2017 |
-535,028.00 |
